This report was recently updated on December 16 2024 with the latest and most recent
market numbers
Global Human Microbiome Market Size, Trends & Analysis - Forecasts to 2029 By Product Type (Prebiotics, Probiotics, Drugs, and Medical Foods), By Disease Type (Infectious, Metabolic, and Endocrine), By Application Type (Diagnostics and Therapeutics), and By Region (North America, Asia Pacific, Central and South America, Europe, and Middle East and Africa), Competitive Landscape, Company Market Share Analysis, and End User Analysis
The global human microbiome market is expected to exhibit a CAGR of 26.4% from 2024 to 2029. Different types of microorganisms exist in body parts such as the skin, mouth, and other surfaces. They come together to create an ecosystem known as the microbiome. These microorganisms are essential for functions in the body, including immune systems and gut health. While many of them are helpful and contribute to functions, any disturbances in the microbiome can result in health issues. This emphasizes the significance of keeping a microbiome within the body.
Many factors drive the growth of the global human microbiome market. One of the most important factors for the growth of the global market is the growing investments from food and beverage companies that produce various prebiotics and probiotics. They invest in researching human microbiomes and the effect of specific microorganisms on human health. Pharmaceutical companies also invest in the market to develop new products targeting specific microorganisms without disturbing the microbiomes. Another key driver for this market growth is the frequent introduction of therapies targeting the well-being of the human microbiome. Pharmaceuticals like live bio-therapeutical products (LBPs) are increasing the demand for research into human microbiomes in the global market, fuelling market growth.
Despite the promising growth prospects, the global human microbiome market faces certain restraints that hinder its growth. One of the key restraints of the market is the challenges faced by research companies due to the complexity of the research. The human microbiome is a very complex research category due to the huge variability in demographic indices and geographic and environmental conditions. These factors raise the research cost, which is a major hindrance for companies willing to invest in the market, impacting market growth.
Based on the application type, the market is segmented into therapeutics and diagnostics. The therapeutics segment is expected to be the largest and fastest-growing segment during the forecast period. This is owing to the rapidly increasing research and development of various therapies and drugs that utilize the human microbiome to produce positive effects on the human body. Several pharmaceutical companies and individual researchers are investing their resources in developing microbiome-based therapies for various medical issues like immune system deviances, metabolic disorders, and digestive health issues. This has made the therapeutics sector the most active and leading area in the global human microbiome market.
On the basis of disease type, the market is segmented into infectious, metabolic, and endocrine. The infectious diseases segment is expected to be the largest and fastest-growing segment during the forecast period. The rapid emergence of resistant bacteria to antibiotics like Staphylococcus aureus has limited the success of treatment methods. As a result, there is now a demand for microbiome-focused treatments such as probiotics, prebiotics, antibiotics, and fecal microbiota transplantation (FMTs) to overcome the challenges posed by traditional approaches.
Based on product type, the market is segmented into prebiotics, probiotics, drugs, and medical foods. The drugs is expected to be the largest segment during the forecast period. Scientists and drug manufacturers emphasize creating medications that take advantage of the association between the human body and its microbiota to address a range of medical ailments. Progress in studying the microbiome has allowed researchers to identify treatment targets, leading to the development of drugs that specifically target the microbiome for conditions such as disorders, autoimmune diseases, and metabolic disorders. This increased emphasis on developing drugs based on the microbiome has made the pharmaceutical sector a player in the market.
The medical food is expected to be the fastest-growing segment in the global human microbiome market during the forecast period. The primary driving factor of this segment is the growing awareness about the importance of healthy foods in maintaining and improving essential body functions like digestion and metabolism. Consumers are adopting a healthy lifestyle by including medical foods like probiotic yogurts and others in their diets, which acts as a market driver for this segment in the global human microbiome market.
North America is expected to hold the largest market share of the global human microbiome market during the forecast period. The region is investing significant funds to research the human microbiome. For instance, on February 5, 2024, the Penn State Eberly College of Science reported receiving a grant of USD 9 million for human microbiome research from the U.S. National Institutes of Health’s National Institute of General Medical Science. Additionally, the North American region is home to countries like the U.S., Canada, and Mexico, which have built a robust technological infrastructure to support human microbiome and drug research, which aids the region in dominating the global human microbiome market.
Asia Pacific is expected to be the fastest-growing region in the global human microbiome market during the forecast period. Asia Pacific is home to countries like China, India, and Japan, which invest significantly in developing multiple products and services related to the human microbiome. The region has observed a rapid increase in the number of firms and institutions like AMILI and Asia Biome conducting human microbiome research, which has led to the growth of the APAC market. Also, investments by various government institutions have increased the market growth rate in the region. For instance, the Indian government launched the Human Microbiome Project in 2019 to map the human microbiome. Additionally, the prevalence of various infectious diseases in the regions leads to increased demand for human microbiome research, accelerating market growth.
Key players operating in the global human microbiome market include AOBiome, Yakult Honsha Co., Metabiomics Corp., Enterome Biosciences SA, Osel Inc., Microbiome Therapeutics LLC, Second Genome, Rebiotix Inc., Synthetic Biologics, and Seres Therapeutics, among others.
Please note: This is not an exhaustive list of companies profiled in the report.
In January 2024, Maruho Co., Ltd. announced that it had entered into an exclusive license agreement with AOBiome, LLC for the treatment of atopic dermatitis. Under the license agreement, AOBiome grants Maruho an exclusive license to develop, manufacture, and commercialize B244 in Japan, and Maruho will pay AOBiome an upfront payment.
In January 2024, Seres Therapeutics, Inc., a leading microbiome therapeutics company, announced preliminary key VOWST launch metrics and receipt of U.S. FDA Fast Track Designation for SER-155 ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference. VOWST, the first U.S. FDA approved orally administered microbiome therapeutic, received U.S. FDA approval in April of 2023 and is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI (rCDI).
1 STRATEGIC INSIGHTS ON NEW REVENUE POCKETS
1.1 Strategic Opportunity & Attractiveness Analysis
1.1.1 Hot Revenue Pockets
1.1.2 Market Attractiveness Score
1.1.3 Revenue Impacting Opportunity
1.1.4 High Growing Region/Country
1.1.5 Competitor Analysis
1.1.6 Consumer Analysis
1.2 Global Market Estimates' View
1.3 Strategic Insights across Business Functions
1.3.1 For Chief Executive Officers
1.3.2 For Chief Marketing Officers
1.3.3 For Chief Strategy Officers
1.4 Evaluate the Potential of your Existing Business Lines vs. New Lines to Enter Into
2 TECHNOLOGICAL TRENDS
2.1 Technological Adoption Rate
2.2 Current Trend Impact Analysis
2.3 Future Trend Impact Analysis
3.1 Market Pyramid Analysis
3.1.1 Introduction
3.1.2 Adjacent Market Opportunities
3.1.3 Ancillary Market Opportunities
3.2 Demand Side Analysis
3.2.1 Market Drivers: Impact Analysis
3.2.2 Market Restraints: Impact Analysis
3.2.3 Market Opportunities: Impact Analysis
3.2.4 Market Challenges: Impact Analysis
3.3 Supply Side Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Threat of New Entrants
3.3.1.2 Threat of New Substitutes
3.3.1.3 Bargaining Power of Suppliers
3.3.1.4 Bargaining Power of Buyers
3.3.1.5 Intensity of Competitive Rivalry
3.3.2 SWOT Analysis; By Factor (Political & Legal, Economic, and Technological)
3.3.2.1 Political Landscape
3.3.2.2 Economic Landscape
3.3.2.3 Social Landscape
3.3.2.4 Technology Landscape
3.3.3 Value Chain Analysis
3.3.4 Trend Analysis
3.3.5 Gap Analysis
3.3.6 Cost Analysis
4 GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE TYPE
4.1 Introduction
4.2 Human Microbiome Market: Disease Type Scope Key Takeaways
4.3 Revenue Growth Analysis, 2023 & 2029
4.4 Infectious
4.4.1 Infectious Market Estimates and Forecast, 2021-2029 (USD Billion)
4.5 Metabolic
4.5.1 Metabolic Market Estimates and Forecast, 2021-2029 (USD Billion)
4.6 Endocrine
4.6.1 Endocrine Market Estimates and Forecast, 2021-2029 (USD Billion)
5 GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT TYPE
5.1 Introduction
5.2 Human Microbiome Market: Product Type Scope Key Takeaways
5.3 Revenue Growth Analysis, 2023 & 2029
5.4 Prebiotics
5.4.1 Prebiotics Market Estimates and Forecast, 2021-2029 (USD Billion)
5.5 Probiotics
5.5.1 Probiotics Market Estimates and Forecast, 2021-2029 (USD Billion)
5.6 Drugs
5.6.1 Drugs Market Estimates and Forecast, 2021-2029 (USD Billion)
5.7 Medical Foods
5.7.1 Medical Foods Market Estimates and Forecast, 2021-2029 (USD Billion)
6 GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION TYPE
6.1 Introduction
6.2 Human Microbiome Market: Application Type Scope Key Takeaways
6.3 Revenue Growth Analysis, 2023 & 2029
6.4 Diagnostics
6.4.1 Diagnostics Market Estimates and Forecast, 2021-2029 (USD Billion)
6.5 Therapeutics
6.5.1 Therapeutics Market Estimates and Forecast, 2021-2029 (USD Billion)
7 GLOBAL HUMAN MICROBIOME MARKET, BY REGION
7.1 Introduction
7.2 North America Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.2.1 By Disease Type
7.2.2 By Product Type
7.2.3 By Application Type
7.2.4 By Country
7.2.4.1 U.S. Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.2.4.1.1 By Disease Type
7.2.4.1.2 By Product Type
7.2.4.1.3 By Application Type
7.2.4.2 Canada Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.2.4.2.1 By Disease Type
7.2.4.2.2 By Product Type
7.2.4.2.3 By Application Type
7.2.4.3 Mexico Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.2.4.3.1 By Disease Type
7.2.4.3.2 By Product Type
7.2.4.3.3 By Application Type
7.3 Europe Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.1 By Disease Type
7.3.2 By Product Type
7.3.3 By Application Type
7.3.4 By Country
7.3.4.1 Germany Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.4.1.1 By Disease Type
7.3.4.1.2 By Product Type
7.3.4.1.3 By Application Type
7.3.4.2 U.K. Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.4.2.1 By Disease Type
7.3.4.2.2 By Product Type
7.3.4.2.3 By Application Type
7.3.4.3 France Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.4.3.1 By Disease Type
7.3.4.3.2 By Product Type
7.3.4.3.3 By Application Type
7.3.4.4 Italy Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.4.4.1 By Disease Type
7.3.4.4.2 By Product Type
7.2.4.4.3 By Application Type
7.3.4.5 Spain Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.4.5.1 By Disease Type
7.3.4.5.2 By Product Type
7.2.4.5.3 By Application Type
7.3.4.6 Netherlands Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.4.7.1 By Disease Type
7.3.4.7.2 By Product Type
7.2.4.7.3 By Application Type
7.3.4.7 Rest of Europe Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.3.4.7.1 By Disease Type
7.3.4.7.2 By Product Type
7.2.4.7.3 By Application Type
7.4 Asia Pacific Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.1 By Disease Type
7.4.2 By Product Type
7.4.3 By Application Type
7.4.4 By Country
7.4.4.1 China Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.1.1 By Disease Type
7.4.4.1.2 By Product Type
7.4.4.1.3 By Application Type
7.4.4.2 Japan Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.2.1 By Disease Type
7.4.4.2.2 By Product Type
7.4.4.2.3 By Application Type
7.4.4.3 India Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.3.1 By Disease Type
7.4.4.3.2 By Product Type
7.4.4.3.3 By Application Type
7.4.4.4 South Korea Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.4.1 By Disease Type
7.4.4.4.2 By Product Type
7.4.4.4.3 By Application Type
7.4.4.5 Singapore Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.5.1 By Disease Type
7.4.4.5.2 By Product Type
7.4.4.5.3 By Application Type
7.4.4.6 Malaysia Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.7.1 By Disease Type
7.4.4.7.2 By Product Type
7.4.4.7.3 By Application Type
7.4.4.7 Thailand Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.7.1 By Disease Type
7.4.4.7.2 By Product Type
7.4.4.7.3 By Application Type
7.4.4.8 Indonesia Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.8.1 By Disease Type
7.4.4.8.2 By Product Type
7.4.4.8.3 By Application Type
7.4.4.9 Vietnam Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.9.1 By Disease Type
7.4.4.9.2 By Product Type
7.4.4.9.3 By Application Type
7.4.4.10 Taiwan Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.10.1 By Disease Type
7.4.4.10.2 By Product Type
7.4.4.10.3 By Application Type
7.4.4.11 Rest of Asia Pacific Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.4.4.11.1 By Disease Type
7.4.4.11.2 By Product Type
7.4.4.11.3 By Application Type
7.5 Middle East and Africa Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5.1 By Disease Type
7.5.2 By Product Type
7.5.3 By Application Type
7.5.4 By Country
7.5.4.1 Saudi Arabia Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5.4.1.1 By Disease Type
7.5.4.1.2 By Product Type
7.5.4.1.3 By Application Type
7.5.4.2 U.A.E. Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5.4.2.1 By Disease Type
7.5.4.2.2 By Product Type
7.5.4.2.3 By Application Type
7.5.4.3 Israel Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5.4.3.1 By Disease Type
7.5.4.3.2 By Product Type
7.5.4.3.3 By Application Type
7.5.4.4 South Africa Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5.4.4.1 By Disease Type
7.5.4.4.2 By Product Type
7.5.4.4.3 By Application Type
7.5.4.5 Rest of Middle East and Africa Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.5.4.5.1 By Disease Type
7.5.4.5.2 By Product Type
7.5.4.5.2 By Application Type
7.6 Central and South America Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.7.1 By Disease Type
7.7.2 By Product Type
7.7.3 By Application Type
7.7.4 By Country
7.7.4.1 Brazil Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.7.4.1.1 By Disease Type
7.7.4.1.2 By Product Type
7.7.4.1.3 By Application Type
7.7.4.2 Argentina Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.7.4.2.1 By Disease Type
7.7.4.2.2 By Product Type
7.7.4.2.3 By Application Type
7.7.4.3 Chile Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.7.4.3.1 By Disease Type
7.7.4.3.2 By Product Type
7.7.4.3.3 By Application Type
7.7.4.4 Rest of Central and South America Human Microbiome Market Estimates and Forecast, 2021-2029 (USD Billion)
7.7.4.4.1 By Disease Type
7.7.4.4.2 By Product Type
7.7.4.4.3 By Application Type
8 COMPETITIVE LANDCAPE
8.1 Company Market Share Analysis
8.2 Four Quadrant Positioning Matrix
8.2.1 Market Leaders
8.2.2 Market Visionaries
8.2.3 Market Challengers
8.2.4 Niche Market Players
8.3 Vendor Landscape
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Rest of the World
8.4 Company Profiles
8.4.1 AOBiome
8.4.1.1 Business Description & Financial Analysis
8.4.1.2 SWOT Analysis
8.4.1.3 Products & Services Offered
8.4.1.4 Strategic Alliances between Business Partners
8.4.2 Yakult Honsha Co.
8.4.2.1 Business Description & Financial Analysis
8.4.2.2 SWOT Analysis
8.4.2.3 Products & Services Offered
8.4.2.4 Strategic Alliances between Business Partners
8.4.3 Metabiomics Corp.
8.4.3.1 Business Description & Financial Analysis
8.4.3.2 SWOT Analysis
8.4.3.3 Products & Services Offered
8.4.3.4 Strategic Alliances between Business Partners
8.4.4 Enterome Biosciences SA
8.4.4.1 Business Description & Financial Analysis
8.4.4.2 SWOT Analysis
8.4.4.3 Products & Services Offered
8.4.4.4 Strategic Alliances between Business Partners
8.4.5 Osel Inc.
8.4.5.1 Business Description & Financial Analysis
8.4.5.2 SWOT Analysis
8.4.5.3 Products & Services Offered
8.4.5.4 Strategic Alliances between Business Partners
8.4.6 Microbiome Therapeutics LLC
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.7.4 Strategic Alliances between Business Partners
8.4.7 Second Genome
8.4.7.1 Business Description & Financial Analysis
8.4.7.2 SWOT Analysis
8.4.7.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.8 Rebiotix Inc.
8.4.8.1 Business Description & Financial Analysis
8.4.8.2 SWOT Analysis
8.4.8.3 Products & Services Offered
8.4.8.4 Strategic Alliances between Business Partners
8.4.9 Synthetic Biologics
8.4.9.1 Business Description & Financial Analysis
8.4.9.2 SWOT Analysis
8.4.9.3 Products & Services Offered
8.4.9.4 Strategic Alliances between Business Partners
8.4.10 Seres Therapeutics
8.4.10.1 Business Description & Financial Analysis
8.4.10.2 SWOT Analysis
8.4.10.3 Products & Services Offered
8.4.10.4 Strategic Alliances between Business Partners
8.4.11 Other Companies
8.4.11.1 Business Description & Financial Analysis
8.4.11.2 SWOT Analysis
8.4.11.3 Products & Services Offered
8.4.11.4 Strategic Alliances between Business Partners
9 RESEARCH OFFERINGOLOGY
9.1 Market Introduction
9.1.1 Market Definition
9.1.2 Market Scope & Segmentation
9.2 Information Procurement
9.2.1 Secondary Research
9.2.1.1 Purchased Databases
9.2.1.2 GMEs Internal Data Repository
9.2.1.3 Secondary Resources & Third Party Perspectives
9.2.1.4 Company Information Sources
9.2.2 Primary Research
9.2.2.1 Various Types of Respondents for Primary Interviews
9.2.2.2 Number of Interviews Conducted throughout the Research Process
9.2.2.3 Primary Stakeholders
9.2.2.4 Discussion Guide for Primary Participants
9.2.3 Expert Panels
9.2.3.1 Expert Panels Across 30+ Industry
9.2.4 Paid Local Experts
9.2.4.1 Paid Local Experts Across 30+ Industry Across each Region
9.3 Market Estimation
9.3.1 Top-Down Approach
9.3.1.1 Macro-Economic Indicators Considered
9.3.1.2 Micro-Economic Indicators Considered
9.3.2 Bottom Up Approach
9.3.2.1 Company Share Analysis Approach
9.3.2.2 Estimation of Potential Product Sales
9.4 Data Triangulation
9.4.1 Data Collection
9.4.2 Time Series, Cross Sectional & Panel Data Analysis
9.4.3 Cluster Analysis
9.5 Analysis and Output
9.5.1 Inhouse AI Based Real Time Analytics Tool
9.5.2 Output From Desk & Primary Research
9.6 Research Assumptions & Limitations
9.7.1 Research Assumptions
9.7.2 Research Limitations
LIST OF TABLES
1 Global Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
2 Infectious Market, By Region, 2021-2029 (USD Billion)
3 Metabolic Market, By Region, 2021-2029 (USD Billion)
4 Endocrine Market, By Region, 2021-2029 (USD Billion)
5 Global Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
6 Prebiotics Market, By Region, 2021-2029 (USD Billion)
7 Probiotics Market, By Region, 2021-2029 (USD Billion)
8 Drugs Market, By Region, 2021-2029 (USD Billion)
9 Medical Foods Market, By Region, 2021-2029 (USD Billion)
10 Global Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
11 Diagnostics Market, By Region, 2021-2029 (USD Billion)
12 Therapeutics Market, By Region, 2021-2029 (USD Billion)
13 Regional Analysis, 2021-2029 (USD Billion)
14 North America Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
15 North America Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
16 North America Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
17 North America Human Microbiome Market, By Country, 2021-2029 (USD Billion)
18 U.S. Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
19 U.S. Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
20 U.S. Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
21 Canada Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
22 Canada Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
23 Canada Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
24 Mexico Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
25 Mexico Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
26 Mexico Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
27 Europe Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
28 Europe Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
29 Europe Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
30 EUROPE Human Microbiome Market, By Country, 2021-2029 (USD Billion)
31 Germany Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
32 Germany Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
33 Germany Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
34 U.K. Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
35 U.K. Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
36 U.K. Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
37 France Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
38 France Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
39 France Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
40 Italy Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
41 Italy Human Microbiome Market, By Product Type Type, 2021-2029 (USD Billion)
42 Italy Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
43 Spain Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
44 Spain Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
45 Spain Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
46 Netherland Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
47 Netherland Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
48 Netherland Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
49 Rest Of Europe Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
50 Rest Of Europe Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
51 Rest of Europe Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
52 Asia Pacific Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
53 Asia Pacific Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
54 Asia Pacific Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
55 Asia Pacific Human Microbiome Market, By Country, 2021-2029 (USD Billion)
56 China Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
57 China Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
58 China Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
59 India Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
60 India Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
61 India Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
62 Japan Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
63 Japan Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
64 Japan Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
65 South Korea Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
66 South Korea Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
67 South Korea Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
68 Australia Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
69 Australia Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
70 Australia Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
71 Thailand Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
72 Thailand Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
73 Thailand Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
74 Vietnam Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
75 Vietnam Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
76 Vietnam Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
77 indonesia Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
78 indonesia Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
79 indonesia Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
80 Malaysia Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
81 Malaysia Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
82 Malaysia Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
83 Philippines Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
84 Philippines Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
85 Philippines Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
86 Singapore Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
87 Singapore Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
88 Singapore Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
89 Rest of APAC Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
90 Rest of APAC Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
91 Rest of APAC Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
92 Middle East and Africa Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
93 Middle East and Africa Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
94 Middle East and Africa Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
95 Middle East and Africa Human Microbiome Market, By Country, 2021-2029 (USD Billion)
96 Saudi Arabia Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
97 Saudi Arabia Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
98 Saudi Arabia Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
99 UAE Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
100 UAE Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
101 UAE Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
102 South Africa Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
103 South Africa Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
104 South Africa Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
105 Israel Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
106 Israel Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
107 Israel Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
108 Rest of Middle East and Africa Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
109 Rest of Middle East and Africa Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
110 Rest of Middle East and Africa Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
111 Central and South America Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
112 Central and South America Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
113 Central and South America Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
114 Central and South America Human Microbiome Market, By Country, 2021-2029 (USD Billion)
115 Brazil Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
116 Brazil Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
117 Brazil Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
118 Argentina Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
119 Argentina Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
120 Argentina Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
121 Chile Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
122 Chile Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
123 Chile Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
124 Rest of Central and South America Human Microbiome Market, By Disease Type, 2021-2029 (USD Billion)
125 Rest of Central and South America Human Microbiome Market, By Product Type, 2021-2029 (USD Billion)
126 Rest of Central and South America Human Microbiome Market, By Application Type, 2021-2029 (USD Billion)
127 AOBiome: Products & Services Offering
128 Yakult Honsha Co.: Products & Services Offering
129 Metabiomics Corp.: Products & Services Offering
130 Enterome Biosciences SA: Products & Services Offering
131 Osel Inc.: Products & Services Offering
132 MICROBIOME THERAPEUTICS LLC: Products & Services Offering
133 Second Genome : Products & Services Offering
134 Rebiotix Inc.: Products & Services Offering
135 Synthetic Biologics: Products & Services Offering
136 Seres Therapeutics: Products & Services Offering
137 Other Companies: Products & Services Offering
LIST OF FIGURES
1 Global Human Microbiome Market Overview
2 Global Human Microbiome Market Value From 2021-2029 (USD Billion)
3 Global Human Microbiome Market Share, By Disease Type (2023)
4 Global Human Microbiome Market Share, By Product Type (2023)
5 Global Human Microbiome Market Share, By Application Type (2023)
6 Global Human Microbiome Market, By Region (Asia Pacific Market)
7 Technological Trends In Global Human Microbiome Market
8 Four Quadrant Competitor Positioning Matrix
9 Impact Of Macro & Micro Indicators On The Market
10 Impact Of Key Drivers On The Global Human Microbiome Market
11 Impact Of Challenges On The Global Human Microbiome Market
12 Porter’s Five Forces Analysis
13 Global Human Microbiome Market: By Disease Type Scope Key Takeaways
14 Global Human Microbiome Market, By Disease Type Segment: Revenue Growth Analysis
15 Infectious Market, By Region, 2021-2029 (USD Billion)
16 Metabolic Market, By Region, 2021-2029 (USD Billion)
17 Endocrine Market, By Region, 2021-2029 (USD Billion)
18 Global Human Microbiome Market: By Product Type Scope Key Takeaways
19 Global Human Microbiome Market, By Product Type Segment: Revenue Growth Analysis
20 Prebiotics Market, By Region, 2021-2029 (USD Billion)
21 Probiotics Market, By Region, 2021-2029 (USD Billion)
22 Drugs Market, By Region, 2021-2029 (USD Billion)
23 Medical Foods Market, By Region, 2021-2029 (USD Billion)
24 Global Human Microbiome Market: By Application Type Scope Key Takeaways
25 Global Human Microbiome Market, By Application Type Segment: Revenue Growth Analysis
26 Diagnostics Market, By Region, 2021-2029 (USD Billion)
27 Therapeutics Market, By Region, 2021-2029 (USD Billion)
28 Regional Segment: Revenue Growth Analysis
29 Global Human Microbiome Market: Regional Analysis
30 North America Human Microbiome Market Overview
31 North America Human Microbiome Market, By Disease Type
32 North America Human Microbiome Market, By Product Type
33 North America Human Microbiome Market, By Application Type
34 North America Human Microbiome Market, By Country
35 U.S. Human Microbiome Market, By Disease Type
36 U.S. Human Microbiome Market, By Product Type
37 U.S. Human Microbiome Market, By Application Type
38 Canada Human Microbiome Market, By Disease Type
39 Canada Human Microbiome Market, By Product Type
40 Canada Human Microbiome Market, By Application Type
41 Mexico Human Microbiome Market, By Disease Type
42 Mexico Human Microbiome Market, By Product Type
43 Mexico Human Microbiome Market, By Application Type
44 Four Quadrant Positioning Matrix
45 Company Market Share Analysis
46 AOBiome: Company Snapshot
47 AOBiome: SWOT Analysis
48 AOBiome: Geographic Presence
49 Yakult Honsha Co.: Company Snapshot
50 Yakult Honsha Co.: SWOT Analysis
51 Yakult Honsha Co.: Geographic Presence
52 Metabiomics Corp.: Company Snapshot
53 Metabiomics Corp.: SWOT Analysis
54 Metabiomics Corp.: Geographic Presence
55 Enterome Biosciences SA: Company Snapshot
56 Enterome Biosciences SA: Swot Analysis
57 Enterome Biosciences SA: Geographic Presence
58 Osel Inc.: Company Snapshot
59 Osel Inc.: SWOT Analysis
60 Osel Inc.: Geographic Presence
61 Microbiome Therapeutics LLC: Company Snapshot
62 Microbiome Therapeutics LLC: SWOT Analysis
63 Microbiome Therapeutics LLC: Geographic Presence
64 Second Genome : Company Snapshot
65 Second Genome : SWOT Analysis
66 Second Genome : Geographic Presence
67 Rebiotix Inc.: Company Snapshot
68 Rebiotix Inc.: SWOT Analysis
69 Rebiotix Inc.: Geographic Presence
70 Synthetic Biologics: Company Snapshot
71 Synthetic Biologics: SWOT Analysis
72 Synthetic Biologics: Geographic Presence
73 Seres Therapeutics: Company Snapshot
74 Seres Therapeutics: SWOT Analysis
75 Seres Therapeutics: Geographic Presence
76 Other Companies: Company Snapshot
77 Other Companies: SWOT Analysis
78 Other Companies: Geographic Presence
The Global Human Microbiome Market has been studied from the year 2019 till 2029. However, the CAGR provided in the report is from the year 2024 to 2029. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Human Microbiome Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
